iCAD acquires VuCOMP’s cancer detection portfolio

Michael Walter | | Radiology Business | Economics

iCAD, a Nashua, N.H.-based cancer detection and radiation therapy technology company, announced this week that it has completed its acquisition of the VuCOMP cancer detection portfolio.

The acquisition includes VuCOMP’s M-Vu computer aided detection (CAD) technology platform, a library of related data, key VuCOMP personnel, and preexisting customers.

Ken Ferry, iCAD CEO, said in a statement that the deal is a big step forward for the company.  

“This acquisition strongly complements iCAD’s strategy and will help accelerate our efforts to bring new and innovative cancer detection and workflow solutions to market, particularly as we prepare to launch our tomosynthesis cancer detection solutions,” Ferry said. “The addition of VuCOMP’s leading researchers and engineers to the iCAD team also represents an important resource for our deep learning technology initiatives aimed at creating improved solutions to help healthcare providers detect cancer early and positions us to maintain and expand our leadership position in the industry in the years ahead.”

According to the company’s statement, iCAD will provide support to VuCOMP M-Vu customers and offer them additional iCAD products and services.

iCAD had previously purchased VuCOMP’s M-Vu Breast Density software back in April 2015. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.